Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.54 | N/A | -5.20% |
management commentary, guidance changes, and full analysis available with Pro.
| -5.20% |
Tone: Defensive
Overall, management expressed concerns about market conditions impacting performance. They are prioritizing cost management to navigate these challenges.
Management acknowledged challenges in the current market environment.
They emphasized a focus on cost control and efficiency improvements.
The earnings report indicates that Prestige Consumer HE faced some headwinds, resulting in a slight miss on EPS. The stock reacted negatively, dropping 6%, likely due to investor concerns about the company's performance and lack of guidance. Management's focus on cost control suggests they are preparing for a challenging market ahead.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SYSCO CORP
May 8, 2017